Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer.

[1]  John T. Wei,et al.  Incidence of initial local therapy among men with lower-risk prostate cancer in the United States. , 2006, Journal of the National Cancer Institute.

[2]  P. Walsh,et al.  Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The Journal of urology.

[3]  K. Harada,et al.  Prediction of potentially insignificant prostate cancer in men undergoing radical prostatectomy for clinically organ‐confined disease , 2005, International journal of urology : official journal of the Japanese Urological Association.

[4]  Alan W Partin,et al.  Characteristics of insignificant clinical T1c prostate tumors , 2004, Cancer.

[5]  Yan Yan,et al.  Relating biopsy and clinical variables to radical prostatectomy findings: can insignificant and advanced prostate cancer be predicted in a screening population? , 2004, Urology.

[6]  Hartwig Huland,et al.  Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors. , 2003, The Journal of urology.

[7]  A. Partin,et al.  Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. , 2003, Urology.

[8]  R T Vollmer,et al.  Percentage carcinoma as a measure of prostatic tumor size in radical prostatectomy tissues. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[9]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.

[10]  A S Whittemore,et al.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.